Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Catheter-Related Infections × Enoxaparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 10 Neoplasms 9 Venous Thrombosis 7 Pancreatic Neoplasms 5 Thromboembolism 4 Pulmonary Embolism 4 Thrombosis 3 Lymphoma 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Ovarian Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Hemorrhage 2 Carcinoma, Non-Small-Cell Lung 2 Venous Thormboembolism 1 Urinary Bladder Neoplasms 1 Thrombocytopenia 1 Stroke 1 Stomach Neoplasms 1 Soft Tissue Neoplasms 1 Multiple Myeloma 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1

Interventions

apixaban 1 Saline Solution 1 Patient Reported Outcome Measures 1 Heparin 1 Enoxaparin 1 Catheters 1 Blood Coagulation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00633061 2020-10-08

DVT

University of Texas Southwestern Medical Center

Phase 2 Terminated

136 enrolled 6 charts

Neoplasms, Venous Thrombosis, Catheter-Related Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡